Abstract
Generalised lipodystrophy of the Berardinelli-Seip type (BSCL) is a rare autosomal recessive human disorder with severe adverse metabolic consequences. A gene on chromosome 9 (BSCL1) has recently been identified, predominantly in African-American families. More recently, mutations in a previously undescribed gene of unknown function (BSCL2) on chromosome 11, termed seipin, have been found to be responsible for this disorder in a number of European and Middle Eastern families. We have studied the genotype/phenotype relationships in 70 affected subjects from 44 apparently unrelated pedigrees of diverse ethnic origin. In all subjects, hepatic dysfunction, hyperlipidaemia, diabetes mellitus, and hypertrophic cardiomyopathy were significant contributors to morbidity with no clear differences in their prevalence between subjects with BSCL1 or BSCL2 and those with evidence against cosegregation with either chromosome 9 or 11 (designated BSCLX). BSCL2 appears to be a more severe disorder than BSCL1 with a higher incidence of premature death and a lower prevalence of partial and/or delayed onset of lipodystrophy. Notably, subjects with BSCL2 had a significantly higher prevalence of intellectual impairment than those with BSCL1 or BSCLX (p<0.0001, OR 17.0, CI 3.6 to 79.0). The higher prevalence of intellectual impairment and the increased risk of premature death in BSCL2 compared to BSCL1 emphasise the importance of molecular diagnosis of this syndrome and have clear implications for genetic counselling.
Full Text
The Full Text of this article is available as a PDF (548.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BERARDINELLI W. An undiagnosed endocrinometabolic syndrome: report of 2 cases. J Clin Endocrinol Metab. 1954 Feb;14(2):193–204. doi: 10.1210/jcem-14-2-193. [DOI] [PubMed] [Google Scholar]
- Brunzell J. D., Shankle S. W., Bethune J. E. Congenital generalized lipodystrophy accompanied by cystic angiomatosis. Ann Intern Med. 1968 Sep;69(3):501–516. doi: 10.7326/0003-4819-69-3-501. [DOI] [PubMed] [Google Scholar]
- Cao H., Hegele R. A. Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet. 2000 Jan 1;9(1):109–112. doi: 10.1093/hmg/9.1.109. [DOI] [PubMed] [Google Scholar]
- Garg A. Lipodystrophies. Am J Med. 2000 Feb;108(2):143–152. doi: 10.1016/s0002-9343(99)00414-3. [DOI] [PubMed] [Google Scholar]
- Garg A., Wilson R., Barnes R., Arioglu E., Zaidi Z., Gurakan F., Kocak N., O'Rahilly S., Taylor S. I., Patel S. B. A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. J Clin Endocrinol Metab. 1999 Sep;84(9):3390–3394. doi: 10.1210/jcem.84.9.6103. [DOI] [PubMed] [Google Scholar]
- Heathcote Kirsten, Rajab Anna, Magré Jocelyne, Syrris Petros, Besti Mehran, Patton Michael, Délépine Marc, Lathrop Mark, Capeau Jacqueline, Jeffery Steve. Molecular analysis of Berardinelli-Seip congenital lipodystrophy in Oman: evidence for multiple loci. Diabetes. 2002 Apr;51(4):1291–1293. doi: 10.2337/diabetes.51.4.1291. [DOI] [PubMed] [Google Scholar]
- Magré J., Delépine M., Khallouf E., Gedde-Dahl T., Jr, Van Maldergem L., Sobel E., Papp J., Meier M., Mégarbané A., Bachy A. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet. 2001 Aug;28(4):365–370. doi: 10.1038/ng585. [DOI] [PubMed] [Google Scholar]
- Mounkes L. C., Burke B., Stewart C. L. The A-type lamins: nuclear structural proteins as a focus for muscular dystrophy and cardiovascular diseases. Trends Cardiovasc Med. 2001 Oct;11(7):280–285. doi: 10.1016/s1050-1738(01)00126-8. [DOI] [PubMed] [Google Scholar]
- Reitman M. L., Arioglu E., Gavrilova O., Taylor S. I. Lipoatrophy revisited. Trends Endocrinol Metab. 2000 Dec;11(10):410–416. doi: 10.1016/s1043-2760(00)00309-x. [DOI] [PubMed] [Google Scholar]
- SEIP M. Lipodystrophy and gigantism with associated endocrine manifestations. A new diencephalic syndrome? Acta Paediatr. 1959 Nov;48:555–574. [PubMed] [Google Scholar]
- Seip M., Trygstad O. Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr Suppl. 1996 Jun;413:2–28. doi: 10.1111/j.1651-2227.1996.tb14262.x. [DOI] [PubMed] [Google Scholar]
- Shackleton S., Lloyd D. J., Jackson S. N., Evans R., Niermeijer M. F., Singh B. M., Schmidt H., Brabant G., Kumar S., Durrington P. N. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet. 2000 Feb;24(2):153–156. doi: 10.1038/72807. [DOI] [PubMed] [Google Scholar]
- Speckman R. A., Garg A., Du F., Bennett L., Veile R., Arioglu E., Taylor S. I., Lovett M., Bowcock A. M. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Am J Hum Genet. 2000 Apr;66(4):1192–1198. doi: 10.1086/302836. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taylor S. I., Arioglu E. Genetically defined forms of diabetes in children. J Clin Endocrinol Metab. 1999 Dec;84(12):4390–4396. doi: 10.1210/jcem.84.12.6237. [DOI] [PubMed] [Google Scholar]
- Vigouroux C., Magré J., Vantyghem M. C., Bourut C., Lascols O., Shackleton S., Lloyd D. J., Guerci B., Padova G., Valensi P. Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. Diabetes. 2000 Nov;49(11):1958–1962. doi: 10.2337/diabetes.49.11.1958. [DOI] [PubMed] [Google Scholar]